BiotechTube

GPI 1485

Phase 2Completed
3 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Parkinson's Disease

Conditions

Parkinson's Disease

Trial Timeline

Nov 1, 2002 → Oct 1, 2005

NCT ID
NCT00209508

About GPI 1485

GPI 1485 is a phase 2 stage product being developed by Eisai for Parkinson's Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00209508. Target conditions include Parkinson's Disease.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson's Disease were approved

Approved (20) Terminated (3) Active (0)
✅Lemborexant + placeboEisaiApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved
✅carbidopa/levodopa + Carbidopa/Levodopa/EntacaponeNovartisApproved
✅carbidopa, levodopa, entacaponeNovartisApproved
✅Levodopa/carbidopa/entacapone + Levodopa/carbidopaNovartisApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00090376Phase 2Completed
NCT00209508Phase 2Completed

Competing Products

20 competing products in Parkinson's Disease

See all competitors
ProductCompanyStageHype Score
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
E2007 + E2007 + E2007EisaiPhase 2
35
E2007EisaiPhase 2
35
E2007EisaiPhase 2
27
E2007EisaiPhase 2
27
2 mg perampanel + 4 mg perampanel + placebo comparatorEisaiPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 2
35
Istradefylline 20 mg or 40 mgKyowa KirinPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 3
40
PerampanelEisaiPhase 2
27